SEC Form 4 · accession 0001104659-18-032155
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith Michael Gottesdiener
Officer — C.E.O. and President · Director
Period of report
May 9, 2018
Accepted (ET)
May 10, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2018 | M | 3,000 | $4.59 | A | 588,539 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.59 | May 9, 2018 | M | 3,000 | D | — | Nov 16, 2025 | Common Stock | 3,000 | 124,780 | D |
Explanation of responses
- F1The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.